Dao-zhen Xu

发表

HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients

Boping Zhou, Q. Ning, Hong Tang, 2016, Virology Journal.

Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients

H. Ren, Lai Wei, J. Hou, 2013, Hepatology International.

Therapeutic effect of hepatitis B surface antigen-antibody complex is associated with cytolytic and non-cytolytic immune responses in hepatitis B patients.

Zheng-hong Yuan, Y. Wen, Jie Zhou, 2007, Vaccine.

The Predictive Value of On-treatment Virological Response for Sustained Virological Response in Chronic Hepatitis C Patients Receiving a Personalized Treatment Program

Hui Zhao, Yao Lu, Jun Cheng, 2013 .

Analysis of immunological mechanisms exerted by HBsAg-HBIG therapeutic vaccine combined with Adefovir in chronic hepatitis B patients

Y. Wen, Zhong-yu Hu, S. Geng, 2017, Human vaccines & immunotherapeutics.

Vaccination with recombinant HBsAg-HBIG complex in healthy adults.

Zheng-hong Yuan, Y. Wen, Dao-zhen Xu, 2005, Vaccine.

Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2 a Retrospective Cohort Study

Shu-jing Song, Min Chang, Minghui Li, 2016 .

[Studies on IgG antibodies of SARS patients].

Ping Li, W. Ling, W. Ou, 2004, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology.

Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: a randomized trial.

Boping Zhou, Q. Ning, R. Mohamed, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

A multicenter, randomized, controlled trial of interferon alfacon‐1 compared with α‐2a‐interferon in Chinese patients with chronic hepatitis C virus infection

G. Yao, L. Hao, Dao-zhen Xu, 2000 .

Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naïve Chinese patients with chronic hepatitis B: a randomized, multicenter study

H. Ren, G. Yao, D. Tan, 2008, Hepatology international.

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double‐blind trial

J. Niu, G. Harb, H. Ren, 2007, Hepatology.

Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China

F. T. P. Group, H. Ren, G. Yao, 2007, Hepatology international.

A Randomized Controlled Phase IIb Trial of Antigen-Antibody Immunogenic Complex Therapeutic Vaccine in Chronic Hepatitis B Patients

Zheng-hong Yuan, Y. Wen, Hui-fen Wang, 2008 .

Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2a.

Jun Cheng, Shu-jing Song, Min Chang, 2016, World journal of hepatology.

[A clinical research on oxymatrine for the treatment of chronic hepatitis B].

Shu-hua Guo, Yan-Yan Yu, Dao-zhen Xu, 2002, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

Entecavir for the treatment of lamivudine-refractory chronic hepatitis B patients in China

H. Ren, Xia-qiu Zhou, G. Yao, 2007, Hepatology international.

[Factors associated with HBeAg seroconversion in chronic hepatitis B patients treated with interferon alfa-2a].

Xinyue Chen, H. Ren, J. Hou, 2007, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients

Boping Zhou, Q. Ning, Hong Tang, 2016, Virology Journal.

HBV DNA level and antigen concentration in evaluating liver damage of patients with chronic hepatitis B.

Hui Zhao, Yao Xie, Dao-zhen Xu, 2003, Hepatobiliary & pancreatic diseases international : HBPD INT.

[Results of 3 years of continuous entecavir treatment in nucleos(t)ide-naive chronic hepatitis B patients].

H. Ren, J. Jia, Xia-qiu Zhou, 2009, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: experiences and findings.

Y. Wen, Hui-fen Wang, H. Ren, 2013, Journal of hepatology.

Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China

F. T. P. Group, H. Ren, G. Yao, 2007, Hepatology International.

[Advances on antigen-antibody immunogenic complex therapeutic vaccine for viral hepatitis B].

Y. Wen, Xuan-Yi Wang, X. Yao, 2009, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B

Z. Goodman, J. Niu, H. Ren, 2015, Advances in Therapy.

[High rates of HBsAg loss and seroconversion result from prolonged course of pegasys treatment].

F. Liu, Hui Zhao, Jun Cheng, 2011, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[Efficacy of pegylated-interferon alpha-2a treatment in patients with HBeAg-positive chronic hepatitis B and partial viral response to nucleoside analogue therapy].

Jun Cheng, Shu-jing Song, Min Chang, 2015, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

The Predictive Value of On-treatment Virological Response for Sustained Virological Response in C h r o n i c H e p a i i s Personalized Treatment Program

Hui Zhao, Shu-jing Song, L. Zhuang, 2017 .

Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C.

Yao Xie, Dao-zhen Xu, Zheng-qin Li, 2005, Hepatobiliary & pancreatic diseases international : HBPD INT.

Application of Molecular Adsorbents Recirculating System to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome

Hong-yu Zhang, Zhong-ping He, Bao-shun Li, 2003, Liver international : official journal of the International Association for the Study of the Liver.

[The treatment of molecular adsorbents recirculating system artificial liver in severe liver failure patients with multiple organ dysfunction syndrome].

Hong-yu Zhang, Zhong-ping He, Bao-shun Li, 2003, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[Expression of intrahepatic CD4+ CD25+ regulatory T cells in patients with chronic hepatitis B].

Z. Lang, B. Shen, Dao-zhen Xu, 2008, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology.

Predictive factors for sustained response to interferon treatment in patients with chronic hepatitis C: a randomized, open, and multi-center controlled trial.

K. Luo, Zhi-meng Lu, G. Zhao, 2005, Hepatobiliary & pancreatic diseases international : HBPD INT.

[A study of the dosage and efficacy of entecavir for treating hepatitis B virus].

Xia-qiu Zhou, G. Yao, Ding-feng Zhang, 2005, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: experiences and findings.

Y. Wen, Hui-fen Wang, H. Ren, 2013, Journal of hepatology.